LIPAC Oncology to Present Two-year Data for Phase 1/2a Study of LiPax
15 Nov 2021 //
BIOSPACE
LIPAC Oncology Announces Positive Data on LiPax
09 Jun 2021 //
PRNEWSWIRE
LIPAC Oncology Announces Successful Type B Meeting with the U.S. FDA
29 Apr 2021 //
PRNEWSWIRE
LIPAC Oncology Announces Major Partnering Milestone Achieved in its Agreement
10 Dec 2020 //
PRESS RELEASE
LIPAC Oncology Announces Completion of Phase 2A Clinical Trial of LiPax
08 Sep 2020 //
BIOSPACE